YA II PN, Ltd. - 13 Dec 2024 SCHEDULE 13G Report for InMed Pharmaceuticals Inc. Common Shares (INM)

Filing Manager
YA II PN, Ltd.
Reporting Manager
YA II PN, Ltd.
Security
InMed Pharmaceuticals Inc. Common Shares
Symbol
INM
Shares outstanding
804,525 shares
Disclosed Ownership
80,372 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
18 Dec 2024, 08:05:00 UTC
Date of event
13 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"YA II PN, Ltd. disclosed 10% ownership in InMed Pharmaceuticals Inc. Common Shares (INM) on 13 Dec 2024."

Quick Takeaways

  • YA II PN, Ltd. filed SCHEDULE 13G for InMed Pharmaceuticals Inc. Common Shares (INM).
  • Disclosed ownership: 10%.
  • Date of event: 13 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 18 Dec 2024, 08:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
YA II PN, Ltd. 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
YA Global Investments II (U.S.), LP 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global, LP 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global II, LLC 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
YA II GP, LP 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP II, LLC 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
Mark Angelo 10% 80,372 0 80,372 /s/ Mark Angelo Mark Angelo
SC-Sigma Global Partners, LP 10% 80,372 0 80,372 /s/ David Gonzalez David Gonzalez, General Counsel
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .